Author:
Avendaño-Tamayo Efren,Rúa Alex,Parra-Marín María Victoria,Rojas Winston,Campo Omer,Chacón-Duque Juan,Agudelo-Flórez Piedad,Narváez Carlos F.,Salgado Doris M.,Restrepo Bertha Nelly,Bedoya Gabriel
Abstract
Introduction: Host genetics is recognized as an influential factor for the development of dengue disease.Objective: This study evaluated the association of dengue with the polymorphisms rs8192284 for gene IL6R, rs3775290 for TLR3, and rs7248637 for DC-SIGN.Materials and methods: Of the 292 surveyed subjects, 191 were confirmed for dengue fever and the remaining 101 were included as controls. The genotypes were resolved using polymerase chain reaction and restriction fragment length polymorphism (PCRRFLP). In an attempt to determine the risk (Odds Ratio) of suffering dengue fever, data were analyzed using chi-square for alleles and logistic regression for both genotypes and allelic combinations. Confidence intervals were set to 95% for all tests regardless of the adjustment by either self-identification or ancestry.Results: For Afro-Colombians, the allele rs8192284 C offered protection against dengue [OR=0.425,(0.204-0.887), p=0.020]. The alleles rs7248637 A and rs3775290 A posed, respectively, an increased risk of dengue for Afro-Colombians [OR=2.389, (1.170-4.879), p=0.015] and Mestizos [OR=2.329, (1.283-4.226), p=0.005]. The reproducibility for rs8192284 C/C [OR=2.45, (1.05-5.76), p=0.013] remained after adjustment by Amerindian ancestry [OR=2.52, (1.04-6.09), p=0.013]. The reproducibility for rs3775290 A/A [OR=2.48, (1.09-5.65), p=0.033] remained after adjustment by European [OR=2.34, (1.02-5.35), p=0.048], Amerindian [OR=2.49, (1.09-5.66), p=0.035], and African ancestry [OR=2.37, (1.04-5.41), p=0.046]. Finally, the association of dengue fever with the allelic combination CAG [OR=2.07, (1.06-4.05), p=0.033] remained after adjustment by Amerindian ancestry [OR=2.16, (1.09-4.28), p=0.028].Conclusions: Polymorphisms rs8192284 for IL6R, rs3775290 for TLR3, and rs7248637 for DC-SIGN were associated with the susceptibility to suffer dengue fever in the sampled Colombian population.
Publisher
Instituto Nacional de Salud (Colombia)
Subject
General Biochemistry, Genetics and Molecular Biology
Reference53 articles.
1. 1. Hadinegoro SR, Arredondo-García JL, Capeding MR, Deseda C, Chotpitayasunondh T, Dietze R, et al. Efficacy and long-term safety of a dengue vaccine in regions of endemic disease. N Engl J Med. 2015;373:1195-206. https://doi.Org/10.1056/NEJMoal 506223
2. 2. Salles TS, da Encarnacao Sa-Guimaraes T, de Alvarenga ES, Guimaraes-Ribeiro V, de Meneses MD, de Castro-Salles PF, ef al. History, epidemiology and diagnostics of dengue in the American and Brazilian contexts: A review. Parasit Vectors. 2018;11:264. https://doi.org/10.1186/sl 3071 -018-2830-8
3. 3. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, ef al. The global distribution and burden of dengue. Nature. 2013;496:504-7. httsp://doi.org/10.1038/nature 12060
4. 4. Mangold KA, Reynolds SL. A review of dengue fever: A resurging tropical disease. Pediatr Emerg Care. 2013;29:665-9. https://doi.Org/10.1097/PEC.0b013e31828ed30e
5. Molecular epidemiology of American/Asian genotype DENV-2 in Perú.;Cruz;Infect Genet Evol,2013